Drug Profile
Estradiol/trimegestone transdermal patch - ProStrakan
Alternative Names: PSK 3987; Trim patch; Trimegestone/estradiol transdermal patch - ProStrakanLatest Information Update: 17 Mar 2009
Price :
$50
*
At a glance
- Originator ProStrakan; sanofi-aventis
- Developer ProStrakan
- Class Estradiol congeners; Estrenes; Hormonal replacements; Norpregnadienes
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Menopausal syndrome
Most Recent Events
- 19 Apr 2006 Clinical development is ongoing
- 11 Oct 2005 PSK 3987 is available for licensing (http://www.strakan.com)
- 22 Sep 2004 ProSkelia has merged with Strakan to form ProStrakan